VR Logo

Ironwood Pharmaceuticals Inc. Class A (IRWD) download report


Healthcare | Drugs & Pharma

Ironwood Pharmaceuticals Inc. Class A (IRWD) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products.

IPO Date: 03-Feb-2010

Exec. Chairman: Ms. Julie H. McHugh

CEO & Director: Mr. Thomas A. McCourt

Listing: NASDAQ: IRWD

Country: United States

Headquarters: Boston, MA

Website: https://www.ironwoodpharma.com

Key Facts

Market cap: $1,784.52 Mln

Revenue (TTM): $422.44 Mln

Earnings (TTM): $527.32 Mln

Cash: $593.37 Mln

Total Debt: $536.76 Mln

Insider's Holding: 1.82%

Liquidity: Low

52 Week range: $10.13 - 14.27

Shares outstanding: 153,838,000

10 Years Aggregate:

  • CFO: $-359.91 Mln
  • EBITDA: $-429.70 Mln
  • Net Profit: $-502.61 Mln

Stock Performance

Time Period Ironwood Pharmaceuticals Inc. Class A (IRWD) S&P BSE Healthcare S&P Small-Cap 600
YTD-3.09-17.32-17.79
1 month-0.62-4.56-2.72
3 months-9.74-10.61-12.17
1 Year-8.87-12.90-15.82
3 Years1.0519.537.14
5 Years-7.179.106.20
10 Years-0.7112.4410.33
As on 24-Jun-2022
Year Ironwood Pharmaceuticals Inc. Class A (IRWD) S&P Small-Cap 600 S&P BSE Healthcare
20212.3725.2720.87
2020-14.439.5761.45
201953.4920.86-3.55
2018-30.75-9.70-5.89
2017-1.9611.730.49
201631.9224.74-12.88
2015-24.35-3.3615.06